2019 Showcasers
3D-BGS
Development and manufacture of synthetic bone grafts using 3D bioprinting
Abfero
AbFero is dedicated to treating diseases of iron-overload
Accentus Medical
World-leading ionic silver surface coatings enabling optimal implant outcomes
Accunea
Continuous real-time monitoring of kidney function
Arctoris
Artoris is combining robotics and AI to beat cancer sooner
Aseptika
Empowering patients to self-manage their long-term conditions
Attomarker
Developing blood testing technology for multiplexed biomarker detection

 
Azul Optics
Creating screening devices that prevent eye disease
BrainWaveBank
Early diagnosis and measurement of treatment response in mental illness
Bridge Biotec
Developing new, peptide medicines, with nanoparticle delivery technology
Celentyx
Human immune system-focused R&D company with 12-year track record
ChemoGel
Thermoresponsive gel drug delivery platform for treatment of solid tumours of the pancreas
Cotton Mouton Diagnostics
Developing a novel and broadly applicable system for bacterial endotoxin testing
East Anglia Therapeutics
Cancer targeted nanoparticles combining molecular therapy with imaging capability
EpiCombi Therapeutics
Machine learning-driven cancer drug combination discovery and precision medicine
GeneFirst
Developing molecular diagnostics technologies for cancer and infectious disease
GyreOx
Bringing new therapeutics to patients via unique macrocycle discovery platform
Hippogen Therapeutics
Developing novel hippo pathway kinase inhibitors as first-in-class cancer therapeutics
InnovoSep
Developing new therapies for sepsis based on Cilengitide
Invizius
Improving poor prognosis of patients on Haemodialysis
Janus Genomics
Empowering biomedical data sharing while preserving data privacy
Kinomica
Developing disruptive technologies for precision medicine
LIG Biowise
Transforming the way we diagnose and treat infectious diseases in the community
LightOx
Developing light based therapeutics for treatment of skin cancers
Linear Diagnostics
Developing a point of care molecular diagnostic platform
Liponext
Developing Novel Lipid Related Therapeutics for Patients Suffering from Kidney Diseases
MicrofluidX
Developing a fully-scalable manufacturing system for cell and gene therapy
Neurocentrx
Ketamine products to treat major depression & improve complex pain management
NSCI Therapeutics
Developing cell-based therapies and biologics for retinal diseases
OmniSpirant
Developing regenerative gene therapies with the potential to transform respiratory medicine
OncoLize
Injectable drug depots containing chemo or immuno for 'treating tumors from the inside'
OR Productivity
Designing & commercialising robots for use in minimal access medicine and surgery
OVO Manufacturing
Improving viral vaccine yield by 10-fold & reducing lead time
Oxford Cancer Biomarkers
Leading-edge biomarker-based diagnostics to improve standards of care in cancer
Oxford Endovascular
Next generation medical devices for neurovascular disease
pHion Therapeutics
Precise & efficient drug delivery for anionic cargo using its peptide-based nanoparticle
PulmonIR
Developing a novel respiratory health assessment platform
Renovos
Developing a nanoclay platform technology solving a key issue for regenerative medicine
Rhythm AI
Software to improve patient outcomes in catheter ablation treatment for Atrial Fibrillation
SAW Diagnostics
Developing complex biological sample analysis technology to facilitate genomic research
Sulfisca Therapeutics
Developing small molecules for metabolic reprogramming
Vascular Silk Technologies
Developing disruptive silk medical implants to fulfill unmet needs of vascular graft market
Vaxinc
University of Southampton spinout developing natural killer cell therapy for cancer
Venue   Contact    

Level39
One Canada Square
Canary Wharf
London E14 5AB


 
 
General Enquiries
E: sarah.walker
@obn.org.uk
T: +44 (0)1235 420870


 
   
Processing. Please wait.
Loading...